23
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Immune memory is tailored by cues that lymphocytes perceive during priming. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic created a situation in which nascent memory could be tracked through additional antigen exposures. Both SARS-CoV-2 infection and vaccination induce multifaceted, functional immune memory, but together they engender improved protection from disease, termed hybrid immunity. We therefore investigated how vaccine-induced memory is shaped by previous infection. We found that following vaccination, previously infected individuals generated more SARS-CoV-2 RBD-specific memory B cells and variant-neutralizing antibodies and a distinct population of IFN-γ and IL-10-expressing memory SARS-CoV-2 spike-specific CD4 + T cells than previously naive individuals. While additional vaccination could increase humoral memory in previously naive individuals, it did not recapitulate the distinct CD4 + T cell cytokine profile observed in previously infected subjects. Thus, imprinted features of SARS-CoV-2-specific memory lymphocytes define hybrid immunity.

          Abstract

          The strong immunity against SARS-CoV-2 in vaccinated individuals that have previously been infected can be explained by a combination of RBD-specific memory B cells, variant-neutralizing antibodies and a specific population of CD4 + T cells.

          Related collections

          Author and article information

          Journal
          Cell
          Cell
          Cell
          Published by Elsevier Inc.
          0092-8674
          1097-4172
          17 March 2022
          17 March 2022
          Affiliations
          [1 ]Department of Immunology, University of Washington School of Medicine, Seattle, WA, 98109, USA
          [2 ]Center for Fundamental Immunology, Benaroya Research Institute, Seattle, WA, 98101, USA
          [3 ]Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, 98109, USA
          [4 ]Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA, 98109, USA
          [5 ]Center for Immunity and Immunotherapies, Seattle Children’s Research Institute, Seattle, WA, 98101, USA
          Author notes
          []Corresponding author
          [6]

          These authors contributed equally

          [7]

          Lead contact

          Article
          S0092-8674(22)00328-2
          10.1016/j.cell.2022.03.018
          8926873
          61c7990b-32fc-48e9-8f07-666eadfe49e8
          © 2022 Published by Elsevier Inc.

          Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

          History
          : 13 January 2022
          : 23 February 2022
          : 14 March 2022
          Categories
          Article

          Cell biology
          sars-cov2,covid-19,memory b cell,memory t cell,hybrid immunity,human,vaccine,adaptive immune response

          Comments

          Comment on this article